Most Recent
After years of pre-trial stoushes, a trademark dispute over Russian vodka has worn a Federal Court judge's patience thin, with the judge remarking that the court was entitled to expect better from the litigants.
Explosives company Dyno Nobel is appealing a court's dismissal of its case seeking to invalidate patents owned by rival Orica for a wireless detonation device.
Genomic sequencing company Oxford Nanopore Technologies has sued MGI Australia alleging infringement of four patents covering nanopore technology.
A judge has thrown out a notice to produce issued by an Australian company being targeted by UK genomic sequencing company Oxford Nanopore Technologies, calling its bid for board minutes and other documents a “fishing expedition”.
A judge has rejected Samsung Bioepis' bid to discover research and development documents from Pfizer as it seeks to invalidate the drug giant's patent for its blockbuster autoimmune drug Enbrel, agreeing with Pfizer that it may be "no more than an exercise in fishing".
Drug giant Pfizer has blasted Samsung Bioepis' “fishing expedition” in its suit alleging infringement of the patent for its blockbuster arthritis drug Enbrel, telling the court the Korean biotech should not be allowed to dig for new grounds of invalidity.
Graphics design platform Canva has overcome opposition to it being granted further time to apply to patent an invention for generating websites, after IP Australia found its US patent attorneys made an "error or omission" by failing to track expiration dates for registering the patent.
Gaming giant Aristocrat Technologies has lost its legal challenge to a decision that rejected a patent for its popular Lightning Link electronic poker machine, after six High Court Justices were equally split on whether it could be patented.
Explosives manufacturer Orica is closer to taking Dyno Nobel to court for allegedly infringing three of its explosives patents, filing proceedings to get more information about its rival's CyberDet wireless detonator device.
Two of the world's largest manufacturers of explosives have taken their fight over three patents for a detonation device to the Federal Court.